SanofiPrefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Sanofi (SNY) reported revenue of $13.28B in Q2 2026.
SanofiFrench pharma. Vaccines €7.936B in 2025: Beyfortus (infant RSV mAb with AstraZeneca), influenza, polio/pertussis/Hib, and travel/endemic. Agreed to acquire Dynavax in December 2025.
Sanofi (SNY) is a Drug Manufacturers - General company. French pharma. Vaccines €7.936B in 2025: Beyfortus (infant RSV mAb with AstraZeneca), influenza, polio/pertussis/Hib, and travel/endemic. Agreed to acquire Dynavax in December 2025. It was founded in 2004, is headquartered in Paris, France and employs about 82,600 people.
Track Sanofi's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated October 3, 2026.
Sterling groups Sanofi in the Vaccines industry, alongside GSK (GSK), Pfizer (PFE) and Merck & Co. (MRK).
If you are researching Sanofi, also look at GSK (GSK), Pfizer (PFE) and Merck & Co. (MRK). You can compare all of them side by side or browse the full Vaccines industry on Sterling.
Q3 2016-Q2 2026
Q3 2016-Q2 2026